Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9)

CHR-NA9; CHRN-A9; N-AChRA9; NAChRA9; N-AChR-A9; Neuronal Acetylcholine Receptor Alpha 9

  • Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9) Packages (Simulation)
  • Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9) Packages (Simulation)
  • RPD147Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9)

USAGE of the Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPD147Hu01 Recombinant Cholinergic Receptor, Nicotinic, Alpha 9 (CHRNa9) Positive Control; Immunogen; SDS-PAGE; WB.
GUESTBOOK